| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
|---|---|
| PPB | platelet-poor blood; pneumococcal pneumonia and bacteremia; positive pressure breathing |
| PPS | Personal Preference Scale; physician, patient and society [course]; polyvalent pneumococcal polysacc... |
| DEV | Duck Embryo Vaccine |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; BÇü Çì¸ðÇʷ罺 ÀÎÇ÷翣ÀÚ ÇǸ· ´Ù´çÁú ¹é½Å... |
| PnC | Pneumococcal C polysaccharide |
|---|---|
| PPS | Pneumococcal polysaccharide |
| PsaA | Pneumococcal surface adhesin A |
| PspA | Pneumococcal surface protein A |
| PCP | pneumococcal capsular polysaccharide |
| ¿µ¹® | vaccine | ÇÑ±Û | ¹é½Å |
|---|---|---|---|
| ¼³¸í | Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©ÇÏ´Â Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °ÈÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù. |
||
| pneumococcal vaccine | Vaccine comprised of purified capsular polysaccharide antigen from 23 types of Streptococcus pneumoniae (representing those types responsible for most of the reported pneumococcal diseases in the U.S.). (05 Mar 2000) |
|---|
| meningitis, pneumococcal | Meningitis caused by bacteria of the species streptococcus pneumoniae. This condition can develop as a complication of pneumococcal pneumonia; by extension from otitis, mastoiditis, or sinusitis; following a skull injury; or without preceding sign of infection elsewhere. (12 Dec 1998) |
|---|---|
| pneumococcal | Pertaining to or containing the pneumococcus. (05 Mar 2000) |
| pneumococcal empyema | Infection of the pleural cavity by Streptococcus pneumoniae, the pneumococcus, with pus formation. Pulsating empyema, a large, tense collection of pus in the pleural cavity through which the cardiac pulsations are transmitted to the chest wall. Streptococcal empyema, purulent exudation into the pleural cavity caused by infection with Streptococcus haemolyticus. (05 Mar 2000) |
| pneumococcal infections | Infections with bacteria of the species streptococcus pneumoniae. (12 Dec 1998) |
| pneumococcal pneumonia | Pneumonia due to infection by Streptococcus pneumoniae; often of lobar distribution. (05 Mar 2000) |
| pneumococcal pneumonia immunization | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| pneumococcal polysaccharide | A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule. Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar. (05 Mar 2000) |
| pneumococcal/suppurative keratitis | A severe, creeping, central, suppurative ulcer often due to pneumococci. Synonym: pneumococcal/suppurative keratitis, serpent ulcer of cornea. (05 Mar 2000) |
| pneumonia, pneumococcal | A febrile disease caused by streptococcus pneumoniae. This condition is characterised by inflammation of one or more lobes of the lungs and symptoms include chills, fever, rapid breathing, and cough. (12 Dec 1998) |
| immunization, pneumococcal pneumonia | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
Synonyms : Pneumovax, Pnu-Imune Vaccine, Pnu Imune Vaccine, PnuImune Vaccine, Polysaccharide Vaccine, Pneumococcal, Vaccine, Pneumococcal Polysaccharide, Vaccines, Pneumococcal
| pneumococcal vaccine |
vaccine (trade name Pneumovax) effective against the 23 most common strains of pneumococcus
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| pneumococcal vaccine |
A killed or weakened form of the pneumococcus bacteria that is given in order to increase a person's immunity to the pneumonia-causing bacteria.
Ãâó: www.ehealthmd.com/library/pneumonia/PNM_glossary.h...
|
| pneumococcal vaccine |
recommended for people over age 65, or those who have a chronic illness, such as diabetes or sickle-cell disease
Ãâó: www.womenandinfants.com/body.cfm
|
| PNEUMOCOCCAL VACCINE | vaccine (trade name Pneumovax) effective against the 23 most common strains of pneumococcus |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|